Skip to Main content Skip to Navigation
Journal articles

Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.

Abstract : Lysphosphatidic acid (LPA) is a major natural bioactive lipid mediator whose biological functions affect multiple organs. These include bone as demonstrated by global Lpar1-knockout mice (Lpar1-/-) which present a bone growth defect. LPA acts on all bone cells including osteoblasts, that are responsible for bone formation, and osteoclasts, which are specialized cells that resorb bone. LPA appears as a potential new coupling molecule during bone remodeling. LPA1 is the most ubiquitous LPA receptor among the six LPA receptor family members (LPA1-6). To better understand the specific role of LPA via its receptor LPA1 in osteoblastic cell lineage we generated osteoblast-specific Lpar1 knockout mice (Lpar1-∆Ob) by crossing Lpar1flox/flox and Osx:Cre+ mouse lines. Lpar1-∆Ob mice do not recapitulate the bone defects of Lpar1-/- mice but revealed reduced bone mineralization and decreased cortical thickness, as well as increased bone porosity associated with an augmentation in the lacunae areas of osteocyte and their apoptotic yield. In vitro, primary Lpar1-∆Ob and immortalized cl1-Ob-Lpar1-/- osteoblasts revealed a remarkable premature expression of alkaline phosphatase, reduced cell proliferation associated with decreased YAP-P nuclear accumulation, and reduced mineralization activity. Osteocyte specification is markedly impaired as demonstrated by reduced expression of early (E11) and late (DMP1, DKK1, SOST) osteocyte markers ex vivo in enriched osteocytic fractions of Lpar1-∆Ob mouse bone explants. In addition, E11 expression and dendrite formation induced by FGF2 are markedly impaired in both primary Lpar1-∆Ob and immortalized cl1-Ob-Lpar1-/- osteoblasts. Taken together these results suggest a new role for LPA in bone mass control via bone mineralization and osteocyte function.
Complete list of metadatas

Cited literature [89 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02611712
Contributor : Olivier Peyruchaud <>
Submitted on : Monday, May 18, 2020 - 3:55:03 PM
Last modification on : Friday, November 20, 2020 - 1:00:07 PM

Files

BBA_ObLPA1_in_bone_2020_Revise...
Files produced by the author(s)

Identifiers

Collections

Citation

Candide Alioli, Léa Demesmay, Sara Laurencin-Dalacieux, Nicolas Beton, Delphine Farlay, et al.. Expression of the type 1 lysophosphatidic acid receptor in osteoblastic cell lineage controls both bone mineralization and osteocyte specification.. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids, Elsevier, 2020, 1865 (8), pp.158715. ⟨10.1016/j.bbalip.2020.158715⟩. ⟨inserm-02611712⟩

Share

Metrics

Record views

68

Files downloads

7